BTK Inhibitors in Multiple Sclerosis Treatment - Part 2

Apr 28, 2025

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts.

Show reference:

https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 

https://www.nejm.org/doi/full/10.1056/NEJMoa2415988